Gene Page:RAB11FIP3
Summary?
| GeneID | 9727 |
| Symbol | RAB11FIP3 |
| Synonyms | CART1|Rab11-FIP3 |
| Description | RAB11 family interacting protein 3 (class II) |
| Reference | MIM:608738|HGNC:HGNC:17224|Ensembl:ENSG00000090565|HPRD:18521|Vega:OTTHUMG00000047843 |
| Gene type | protein-coding |
| Map location | 16p13.3 |
| Pascal p-value | 0.045 |
| Sherlock p-value | 0.382 |
| eGene | Frontal Cortex BA9 元 |
Gene in Data Sources
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
死神:胎儿(13 - 26所示postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
| Top 10 positively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| PIP5K1A | 0.85 | 0.90 |
| ZFP64 | 0.84 | 0.87 |
| WDR26 | 0.84 | 0.87 |
| GOLPH3 | 0.83 | 0.88 |
| FBXO38 | 0.83 | 0.88 |
| TMCO7 | 0.83 | 0.85 |
| IPO5 | 0.83 | 0.89 |
| DDB1 | 0.83 | 0.87 |
| WDR82 | 0.83 | 0.89 |
| FBXO21 | 0.83 | 0.88 |
| Top 10 negatively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| FXYD1 | -0.70 | -0.82 |
| MT-CO2 | -0.69 | -0.82 |
| AF347015.33 | -0.67 | -0.78 |
| AF347015.31 | -0.67 | -0.78 |
| MT-CYB | -0.66 | -0.78 |
| AF347015.8 | -0.66 | -0.80 |
| AF347015.27 | -0.65 | -0.78 |
| HIGD1B | -0.65 | -0.77 |
| S100B | -0.65 | -0.75 |
| IFI27 | -0.65 | -0.77 |
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| KEGG ENDOCYTOSIS | 183 | 132 | All SZGR 2.0 genes in this pathway |
| PID ARF6 DOWNSTREAM PATHWAY | 15 | 14 | All SZGR 2.0 genes in this pathway |
| PARENT MTOR SIGNALING UP | 567 | 375 | All SZGR 2.0 genes in this pathway |
| LIU TARGETS OF VMYB VS CMYB UP | 20 | 12 | All SZGR 2.0 genes in this pathway |
| CHARAFE BREAST CANCER LUMINAL VS BASAL UP | 380 | 215 | All SZGR 2.0 genes in this pathway |
| WAMUNYOKOLI OVARIAN CANCER LMP DN | 199 | 124 | All SZGR 2.0 genes in this pathway |
| PEREZ TP63 TARGETS | 355 | 243 | All SZGR 2.0 genes in this pathway |
| PEREZ TP53 AND TP63 TARGETS | 205 | 145 | All SZGR 2.0 genes in this pathway |
| BENPORATH ES WITH H3K27ME3 | 1118 | 744 | All SZGR 2.0 genes in this pathway |
| NIKOLSKY BREAST CANCER 16P13 AMPLICON | 120 | 49 | All SZGR 2.0 genes in this pathway |
| PENG RAPAMYCIN RESPONSE UP | 203 | 130 | All SZGR 2.0 genes in this pathway |
| CREIGHTON ENDOCRINE THERAPY RESISTANCE 4 | 307 | 185 | All SZGR 2.0 genes in this pathway |
| MASSARWEH TAMOXIFEN RESISTANCE DN | 258 | 160 | All SZGR 2.0 genes in this pathway |
| VANTVEER BREAST CANCER ESR1 UP | 167 | 99 | All SZGR 2.0 genes in this pathway |
| YAGI AML WITH INV 16 TRANSLOCATION | 422 | 277 | All SZGR 2.0 genes in this pathway |
| CAIRO LIVER DEVELOPMENT UP | 166 | 105 | All SZGR 2.0 genes in this pathway |
| MARTENS BOUND BY PML RARA FUSION | 456 | 287 | All SZGR 2.0 genes in this pathway |
| BHAT ESR1 TARGETS VIA AKT1 UP | 281 | 183 | All SZGR 2.0 genes in this pathway |